Evidence map›Paper›PMID 37233751›Full record

ReviewClinical research in cardiology : official journal of the German Cardiac Society2024

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists.

Alvar Agusti, Michael Böhm, Bartolomé Celli, Gerard J Criner, Ana Garcia-Alvarez, Fernando Martinez, Don D Sin, Claus F Vogelmeier

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Clinical research in cardiology : official journal of the German Cardiac Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06503315 (Genetic Polymorphism in Matrix Metalloproteinase 9 in Chronic Obstructive Pulmonary Disease in Sohag University Hospital.), which is not on this map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
11.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06503315 unknown statusnot on this map

Genetic Polymorphism in Matrix Metalloproteinase 9 in Chronic Obstructive Pulmonary Disease in Sohag University Hospital.

TypeobservationalSponsorSohag UniversityRan2024 to 2026Enrolled70ConditionsChronic Obstructive Pulmonary Disease
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Association ofAnnals of medicine · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 4 countries.

Alvar AgustiHospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Michael BöhmKardiologieAngiologie und Internistische Intensivmedizin, Universitätsklinikum des SaarlandesKlinik für Innere Medizin III, Saarland University, Homburg/Saar, Germany.
Bartolomé CelliBrigham and Women's Hospital, Harvard Medical School, Boston, USA.
Gerard J CrinerDepartment of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine, Philadelphia, PA, USA.
Ana Garcia-AlvarezHospital Clinic, IDIBAPS, University of Barcelona, Barcelona, Spain.
Fernando MartinezWeill Cornell Medicine, NYPresbyterian Hospital, New York, NY, USA.
Don D SinCentre for Heart Lung Innovation, Department of Medicine (Division of Respirology), St. Paul's Hospital, University of British Columbia, Vancouver, Canada.
Claus F VogelmeierDepartment of Medicine, Pulmonary and Critical Care Medicine, Member of the German Center for Lung Research (DZL), University of Marburg, Marburg, Germany. vogelmei@med.uni-marburg.de.ORCID http://orcid.org/0000-0002-9798-2527
Hospital Clínic de Barcelona · ESBrigham and Women's Hospital · USCornell University · USGerman Center for Lung Research · DEPhiladelphia University · USUniversitätsklinikum des Saarlandes · DEUniversity of British Columbia · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many patients seen by cardiologists suffer chronic obstructive pulmonary disease (COPD) in addition to their primary cardiovascular problem. Yet, quite often COPD has not been diagnosed and, consequently, patients have not been treated of their pulmonary disease. Recognizing and treating COPD in patients with CVDs is important because optimal treatment of the COPD carries important benefits on cardiovascular outcomes. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) publishes an annual report that serves as a clinical guideline for the diagnosis and management of COPD around the world and has very recently released the 2023 annual report. Here, we provide a summary of the GOLD 2023 recommendations that highlights those aspects of more interest for practicing cardiologists dealing with patients with CVD who may suffer COPD.

Indexed as

CardiologistsPulmonary Disease, Chronic ObstructiveHumansLungChronic bronchitisEmphysemaGOLDSmokingTobacco

Identifiers

PMID37233751
PMCPMC10215047
OpenAlexW4378349228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.